Bio Break: Funding Strategies for Medical Devices
Nick and Joris tackle a topic that’s more relevant than ever—raising funds for medical device development in today’s challenging financial landscape. With economic headwinds and cautious investors, startups and even established organizations face significant hurdles in securing funding. But there are ways to mitigate these challenges, and Joris shares strategic insights to align product development milestones with fundraising cycles.
Joris explains how breaking down a development program into distinct phases can help demonstrate progress and reduce risk, making a strong case to investors. Starting with an early-stage proof-of-concept system, developers can validate that their technology works as intended. This milestone not only reduces technical risk but also provides a compelling signal to potential investors that the project is on the right track.
The discussion highlights how subsequent phases build on this foundation, with the next funding round often focused on achieving clinical efficacy or regulatory submissions. These milestones unlock further investment, ensuring that the project continues to move forward incrementally. Finally, Joris emphasizes the importance of manufacturability and scalability, particularly for larger organizations aiming to bring the product to market. Demonstrating the ability to scale up production efficiently can attract interest from strategic partners or investors looking for a proven product ready for commercialization.
Nick and Joris also explore how this phased approach aligns with increasing funding needs while simultaneously de-risking the project. As the product progresses through proof of concept, clinical trials, and manufacturing, the price tag grows—but so does investor confidence, creating a balanced, stage-gated strategy for success.
Whether you’re a startup navigating tight budgets or an established company seeking to optimize your funding strategy, this episode is packed with actionable advice for managing financial risk in medical device development. Watch this Bio Break episode to learn how thoughtful planning and clear milestones can secure the funding you need to bring innovative medical technologies to life!
Funding Strategies for Medical Devices
Related Resources
Nick and Joris explore the fascinating world of repurposing existing medical device technologies for new market sectors. As engineers and innovators, we often focus on creating brand-new solutions, but what about leveraging tried-and-true technologies to expand into untapped markets? This strategy not only opens doors to new revenue streams but also maximizes the potential of existing innovations.
In this episode of Bio Break, Nick Allan and Joris van der Heijden tackle the fascinating challenge of targeted drug delivery. When administering drugs to specific areas in the body, how can we be certain they reach the intended target? Nick shares an exciting example involving an intranasal device designed to deliver drugs precisely to the olfactory cleft—an area located between the eyes.
Nick Allan and Joris van der Heijden dive into a critical concept in drug delivery and biopharmaceutical development: shear stress. Understanding shear stress, especially when dealing with delicate therapies like cell and gene treatments or mRNA vaccines, can have profound effects on drug viability and efficacy. Nick walks us through how shear stress is identified, measured, and mitigated during product design and development.
Nick Allan and Joris van der Heijden delve into the fascinating world of drug delivery systems, focusing on the innovative use of nebulizers. While traditional methods like pills and injections dominate the landscape, nebulizers offer a unique, efficient, and non-invasive alternative for administering medications.